Figure 5
Figure 5. Expression of the aGVHD miRNA signature in sepsis or lung transplant patients. (A) Expression levels of the aGVHD miRNA signature including miR-423, miR-199a-3p, miR-93*, miR-377, miR-155, and miR-30a in plasma of lung transplant patients with (n = 17) or without (n = 28) acute rejection. (B) Expression levels of the aGVHD miRNA signature in plasma of sepsis patients (n = 38) and healthy donors (n = 10). HD, healthy donors; NS, nonsignificant.

Expression of the aGVHD miRNA signature in sepsis or lung transplant patients. (A) Expression levels of the aGVHD miRNA signature including miR-423, miR-199a-3p, miR-93*, miR-377, miR-155, and miR-30a in plasma of lung transplant patients with (n = 17) or without (n = 28) acute rejection. (B) Expression levels of the aGVHD miRNA signature in plasma of sepsis patients (n = 38) and healthy donors (n = 10). HD, healthy donors; NS, nonsignificant.

Close Modal

or Create an Account

Close Modal
Close Modal